Two Sigma Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,400
Closed -$2.97M 2972
2022
Q2
$2.97M Sell
20,400
-136,963
-87% -$20M 0.01% 949
2022
Q1
$18.7M Sell
157,363
-42,430
-21% -$5.03M 0.06% 398
2021
Q4
$27.5M Buy
199,793
+33,771
+20% +$4.65M 0.06% 348
2021
Q3
$23.1M Buy
166,022
+120,165
+262% +$16.7M 0.05% 366
2021
Q2
$4.45M Sell
45,857
-90,748
-66% -$8.81M 0.01% 966
2021
Q1
$9.34M Sell
136,605
-59,270
-30% -$4.05M 0.02% 600
2020
Q4
$16.8M Sell
195,875
-79,990
-29% -$6.86M 0.05% 374
2020
Q3
$17.9M Buy
275,865
+189,121
+218% +$12.3M 0.06% 287
2020
Q2
$6.34M Buy
86,744
+1,781
+2% +$130K 0.03% 460
2020
Q1
$2.89M Sell
84,963
-164,516
-66% -$5.6M 0.02% 574
2019
Q4
$13.6M Buy
249,479
+189,419
+315% +$10.3M 0.04% 431
2019
Q3
$2.51M Buy
60,060
+44,360
+283% +$1.85M 0.01% 849
2019
Q2
$688K Sell
15,700
-211,966
-93% -$9.29M ﹤0.01% 1484
2019
Q1
$11.7M Buy
+227,666
New +$11.7M 0.04% 523
2017
Q3
Sell
-13,618
Closed -$340K 2511
2017
Q2
$340K Buy
+13,618
New +$340K ﹤0.01% 1751